Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2011, Vol. 16 ›› Issue (1): 93-97.

Previous Articles     Next Articles

Effect of Ulinastation on intra-abdominal hypertension and intestinal mucosa barrier in older patients with severe acute pancreatitis

MA Jing1, GU Pei-yu1,YU Zhui2   

  1. 1Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Techology,
    2The Frist Attached Hospital, Medical College of Wuhan University, Wuhan 430072, Hubei,China
  • Received:2010-10-25 Revised:2010-12-25 Published:2020-09-16

Abstract: AIM: To study the effect of Ulinastation(UTI) on intra-abdominal hypertension(IAP) and intestinal mucosa barrier in older patients with severe acute pancreatitis.METHODS: To divide 48 older patients with severe acute pancreatitis into treatment group(n=24) and contral group(n=24) randomly, including continuous blood purification(CBP).Both treatment group and control group were given conventional therapy,and ulinastatin was added to the treatment group. The changes of intra-abdominal pressure, IL-6,DAO, IgA were observed and compared in 24 and 48 hours.RESULTS: The level of IAP before treatment was (17.45±1.87)mm Hg, which was positively associated with the level of IL-6(P<0.01). The intra-abdominal pressure,IL-6, DAO level were decreased and IgA was increased significantly in both groups after treatment(P<0.01). Compared with the control group, there were no significant difference between these results and those of control group before treatment,but significantly the intra-abdominal pressure,IL-6, DAO level were decreased and IgA was increased significantly at 48 hours and IL-6 was decreased at 24 hours after treatment(P<0.01). CONCLUSION: The conventional therapy plus ulinastatin for older patients with acute acute pancreatitis can improve intra-abdominal hypertension and shelter the function of intestinal mucosa by anti-inflammatory effect.

Key words: Ulinastation, Older patient, Severe acute pancreatitis, Function of intestinal mucosa  ,  ,  ,  ,  

CLC Number: